Members of the Siuzdak lab have discovered a molecule that appears be a critical component of chronic pain as well as a potential new drug target.
“Since the development of drugs that target RNA is extremely challenging, these studies can open up new avenues to exploit RNA drug targets that cause a host of RNA-mediated diseases,” says Associate Professor Matthew Disney.
Meet Tatiana Domitrovic, research associate in the Jack Johnson lab.